Overview

Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer

Status:
Recruiting

Trial end date:
2024-09-01

Target enrollment:

Participant gender:

Summary

In this study, The researchers sought to explore the efficacy and safety of involving field radiotherapy in the oligo-metastatic/recurrent/refractory ovarian cancer patients among different groups which include drug therapy alone, radiotherapy alone, and drug therapy plus radiotherapy by inviting clinical multi-center participation.

Phase:

N/A

Details

Lead Sponsor:

Health Science Center of Xi'an Jiaotong University

Treatments:

Coal Tar